Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. 1986

A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston

The effect and plasma concentrations of vecuronium bromide were measured in normal patients after an intravenous dose of 50, 100, or 150 micrograms/kg and in patients with renal failure after 50 or 100 micrograms/kg. Urinary excretion of vecuronium was studied in normal patients after the 150 micrograms/kg dose. Pharmacokinetic parameters of patients with or without renal failure were similar. No metabolites of vecuronium were found in the plasma. Twenty percent of vecuronium was excreted unchanged in the urine; 5% as the 3-hydroxy derivative. No other metabolites of vecuronium were found in the urine. Increasing doses of vecuronium shortened the onset, but prolonged the duration of action and the recovery rate, to a similar extent in patients with or without renal failure. It was concluded that the disposition of vecuronium was best described by a three compartment model. Both the disposition and the effect of vecuronium are only marginally disturbed by renal failure.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009466 Neuromuscular Blocking Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. Neuromuscular Blocker,Neuromuscular Blocking Agent,Neuromuscular Blockers,Agent, Neuromuscular Blocking,Agents, Neuromuscular Blocking,Blocker, Neuromuscular,Blockers, Neuromuscular,Blocking Agent, Neuromuscular,Blocking Agents, Neuromuscular
D010197 Pancuronium A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. Pancuronium Bromide,Pancuronium Curamed,Pancuronium Organon,Pavulon,Bromide, Pancuronium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
August 1988, Anesthesiology,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
July 1990, Masui. The Japanese journal of anesthesiology,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
January 1975, Clinical and experimental pharmacology & physiology,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
April 1985, Acta anaesthesiologica Scandinavica,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
January 1986, Acta anaesthesiologica Belgica,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
November 1996, Clinical pharmacology and therapeutics,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
November 1992, Anesthesiology,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
December 2015, Clinical journal of the American Society of Nephrology : CJASN,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
September 1984, British journal of anaesthesia,
A F Bencini, and A H Scaf, and Y J Sohn, and C Meistelman, and A Lienhart, and U W Kersten, and S Schwarz, and S Agoston
August 1967, Postgraduate medical journal,
Copied contents to your clipboard!